Search Results

Clinical trials: Japan's opt-out policy raises risks of adverse drug responses.

• Authors : Namba M; Kaneda Y; Ozaki A

Subjects: Drug Approval*/Drug Approval*/Drug Approval*/legislation & jurisprudence ; Drug Approval*/Drug Approval*/Drug Approval*/methods ; Drug-Related Side Effects and Adverse Reactions*

• Source: Nature [Nature] 2024 Feb; Vol. 626 (7998), pp. 261.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium: Internet ISSN:

Record details

COLD COMFORT.

• Authors : HATTON, RANDY C. (AUTHOR)

Subjects: FREEDOM of Information Act (U.S.); DRUG approval

• Source: Scientific American. Mar2024, Vol. 330 Issue 3, p64-69. 6p. 2 Color Photographs, 1 Diagram.

Record details

FDA-Approved Drugs to Treat Dementia.

Subjects: Drug Approval* ; Dementia*/Dementia*/Dementia*/drug therapy; Humans

• Source: Journal of psychosocial nursing and mental health services [J Psychosoc Nurs Ment Health Serv] 2024 Apr; Vol. 62 (4), pp. 5. Date of Electronic Publication: 2024 Apr 01.Publisher: C.B. Slack Country of Publication: United States NLM ID: 8200911 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

News Brief: The FDA grants Florida approval to import drugs from Canada.

Subjects: Drug Approval*; Humans ; United States

• Source: The American journal of nursing [Am J Nurs] 2024 Apr 01; Vol. 124 (4), pp. 15. Date of Electronic Publication: 2024 Mar 21.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0372646 Publication Model: Print-Electronic Cited Medium:

Record details

Upcoming market catalysts in Q2 2024.

• Authors : Shui-Jezierski A

Subjects: Drug Design* ; Drug Approval*; Humans

• Source: Nature reviews. Drug discovery [Nat Rev Drug Discov] 2024 Apr; Vol. 23 (4), pp. 241.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124171 Publication Model: Print Cited Medium: Internet ISSN: 1474-1784

Record details

The Critical Intersect of Regulations, Health Technology Assessment, and Drug Safety Assessments.

• Authors : Yang WW; Data Science Center, Fu Jen Catholic University, No. 510, Zhongzheng Rd., Xinzhuang Dist., New Taipei City, 242062, Taiwan, R.O.C.; Health Outcomes and Technology Teaching and Education Alliance, Taipei City, Taiwan, R.O.C.

Subjects: Technology Assessment, Biomedical* ; Drug Approval*; Humans

• Source: Drug safety [Drug Saf] 2024 Apr; Vol. 47 (4), pp. 289-299. Date of Electronic Publication: 2023 Dec 19.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Synthetic Approaches to the New Drugs Approved During 2022.

• Authors : France SP; Process Research and Development, Merck & Co., Rahway, NJ 07065, United States.; Lindsey EA

Subjects: Drug Approval*; United States ; Japan

• Source: Journal of medicinal chemistry [J Med Chem] 2024 Mar 28; Vol. 67 (6), pp. 4376-4418. Date of Electronic Publication: 2024 Mar 15.Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet

Record details

FDA Greenlights First Treatment for Severe Food Allergies.

• Authors : Harris E

Subjects: Food Hypersensitivity*/Food Hypersensitivity*/Food Hypersensitivity*/drug therapy ; Drug Approval*; Humans

• Source: JAMA [JAMA] 2024 Mar 26; Vol. 331 (12), pp. 1002.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN:

Record details

The evolutionary safety of mutagenic drugs should be assessed before drug approval.

• Authors : Lobinska G; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.; Tretyachenko V

Subjects: Drug Approval* ; Mutagens*/Mutagens*/Mutagens*/toxicity; Mutagenesis

• Source: PLoS biology [PLoS Biol] 2024 Mar 15; Vol. 22 (3), pp. e3002570. Date of Electronic Publication: 2024 Mar 15 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101183755 Publication Model: eCollection Cited Medium: Internet

Record details

Adapting and Advancing the Criteria for Scientific Evidence, Marketing, and Advice in the Changing World.

• Authors : Maron JL; Department of Pediatrics, Division of Newborn Medicine, Women and Infants Hospital of Rhode Island, Providence, Rhode Island.

Subjects: Marketing* ; Drug Approval*; Humans

• Source: Clinical therapeutics [Clin Ther] 2024 Mar; Vol. 46 (3), pp. 185. Date of Electronic Publication: 2024 Mar 19.Publisher: Excerpta Medica Country of Publication: United States NLM ID: 7706726 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details